Some pharmacological effects of tetracyclic thymoleptic maprotiline in comparison with tricyclic antidepressants
Benesová, O.; Kasalický, B.; Metysová, J.
Activitas Nervosa Superior 15(2): 107-108
1973
ISSN/ISBN: 0001-7604 PMID: 4752635 Document Number: 58177
Document emailed within 1 workday
Related Documents
Rysánek, K.; Benesová, O.; Spánková, H. 1974: Comparison of the effects of tetracyclic and tricyclic antidepressants on the serotonin uptake by human thrombocytes in vitro Activitas Nervosa Superior 16(4): 307-308Goldman, L.S.; Alexander, R.C.; Luchins, D.J. 1986: Monoamine oxidase inhibitors and tricyclic antidepressants: comparison of their cardiovascular effects Journal of Clinical Psychiatry 47(5): 225-229
Zácková, P.; Kunová, A.; Benetková, M. 1989: Different cardiovascular effects of tricyclic antidepressants in the conscious and anesthetized rats Activitas Nervosa Superior 31(1): 31-32
Biamino, G.; Fenner, H.; Schüren, K.P.; Neye, J.; Ramdohr, B.; Lohmann, R.W. 1975: Cardiovascular side effects of tricyclic antidepressants - a risk in the use of these drugs International Journal of Clinical Pharmacology and Biopharmacy 11(3): 253-261
Rasmussen, S.; Quedens, J.H. 1991: Possible cross hepatotoxicity between tricyclic and tetracyclic antidepressive agents Ugeskrift for Laeger 153(43): 3020-3022
Lipscomb, P.A. 1980: Cardiovascular side effects of phenothiazines and tricyclic antidepressants. A review with precautionary measures Postgraduate Medicine 67(3): 189-92 195-6
Biamino, G.; Fenner, H.; Neye, J.; Schuren, K.P.; Ramdohr, B. 1975: Comparative in vitro and in vivo studies on the effects of tricyclic antidepressants on myocardial contractility Recent Advances in Studies on Cardiac Structure and Metabolism 10: 59-69
Costa, J.; de Oliveira, E.I.; Rosa, M.M.; Ferreira, J.J.; Sampaio, C.; Carneiro, A.V. 2001: Cardiac effects of acute poisoning with tricyclic antidepressants: systematic review of the literature -- Part IV Revista Portuguesa de Cardiologia: Orgao Oficial da Sociedade Portuguesa de Cardiologia 20(10): 1021-1030
Pacher, P.; Ungvari, Z.; Kecskemeti, V.; Furst, S. 1998: Review of cardiovascular effects of fluoxetine, a selective serotonin reuptake inhibitor, compared to tricyclic antidepressants Current Medicinal Chemistry 5(5): 381-390
Finke, G.; Wegener, G. 1982: Comparison of the therapeutic effects of lofepramine and maprotiline in depression Münchener Medizinische Wochenschrift 124(12): 301-303
Pawłowski, L.; Nowak, G. 1987: Biochemical and pharmacological tests for the prediction of ability of monoamine uptake blockers to inhibit the uptake of noradrenaline in-vivo: the effects of desipramine, maprotiline, femoxetine and citalopram Journal of Pharmacy and Pharmacology 39(12): 1003-1009
Spiker, D.G. 1978: The toxicity of tricyclic antidepressants Communications in Psychopharmacology 2(5): 419-427
Jackson, W.K.; Roose, S.P.; Glassman, A.H. 1987: Cardiovascular toxicity and tricyclic antidepressants Biomedicine and PharmacoTherapy 41(7): 377-382
Chodorowski, Z.; Anand, J.S. 1999: Suicidal poisoning with tricyclic antidepressants Przeglad Lekarski 56(6): 438-441
1993: Tricyclic antidepressants: advantages and limitations Geriatrics 48 Suppl. 2: 6-8
Gwynne, J.F. 1971: Tricyclic antidepressants and heart disease New Zealand Medical Journal 74(475): 414-415
Judd, F.; Boyce, P. 1999: Tricyclic antidepressants in the treatment of depression. do they still have a place? Australian Family Physician 28(8): 809-813
Small, G.W. 1989: Tricyclic antidepressants for medically ill geriatric patients Journal of Clinical Psychiatry 50 Suppl: 27-31; Discussion: 32-33
Braithwaite, R.A. 1980: Plasma-protein binding of tricyclic antidepressants Postgraduate Medical Journal 56(Suppl 1): 107-111
Syrek, M.; Wójcikowski, J.; Daniel, W.A. 1997: Promazine pharmacokinetics during concurrent treatment with tricyclic antidepressants Polish Journal of Pharmacology 49(6): 453-462